Literature DB >> 17228328

Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer.

Stephanie Baert-Desurmont1, Marie-Pierre Buisine, Emilie Bessenay, Stephanie Frerot, Tonio Lovecchio, Cosette Martin, Sylviane Olschwang, Qing Wang, Thierry Frebourg.   

Abstract

Numerous reports have highlighted the contribution of MSH2 and MLH1 genomic deletions to hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch's syndrome, but genomic duplications of these genes have been rarely reported. Using quantitative multiplex PCR of short fluorescent fragments (QMPSF), 962 and 611 index cases were, respectively, screened for MSH2 and MLH1 genomic rearrangements. This allowed us to detect, in 11 families, seven MSH2 duplications affecting exons 1-2-3, exons 4-5-6, exon 7, exons 7-8, exons 9-10, exon 11, and exon 15, and three MLH1 duplications affecting exons 2-3, exon 4 and exons 6-7-8. All duplications were confirmed by an independent method. The contribution of genomic duplications of MSH2 and MLH1 to HNPCC can therefore be estimated approximately to 1% of the HNPCC cases. Although this frequency is much lower than that of genomic deletions, the presence of MSH2 or MLH1 genomic duplications should be considered in HNPCC families without detectable point mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17228328     DOI: 10.1038/sj.ejhg.5201765

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  5 in total

1.  The three nucleotide deletion within the 3'untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome.

Authors:  J Tinat; S Baert-Desurmont; J B Latouche; S Vasseur; C Martin; E Bouvignies; T Frébourg
Journal:  Fam Cancer       Date:  2008-05-22       Impact factor: 2.375

2.  Partial duplication of MSH2 spanning exons 7 through 14 in Lynch syndrome.

Authors:  Mikio Shiozawa; Yasuyuki Miyakura; Makiko Tahara; Kazue Morishima; Hidetoshi Kumano; Koji Koinuma; Hisanaga Horie; Alan T Lefor; Naohiro Sata; Yoshikazu Yasuda; Kenji Gonda; Seiichi Takenoshita; Akihiko Tamura; Noriyoshi Fukushima; Kokichi Sugano
Journal:  J Gastroenterol       Date:  2013-04-18       Impact factor: 7.527

3.  Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.

Authors:  Georgia Thodi; Florentia Fostira; Raphael Sandaltzopoulos; George Nasioulas; Anastasios Grivas; Ioannis Boukovinas; Maria Mylonaki; Christos Panopoulos; Mirjana Brankovic Magic; George Fountzilas; Drakoulis Yannoukakos
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430

4.  A rare large duplication of MLH1 identified in Lynch syndrome.

Authors:  Abhishek Kumar; Nagarajan Paramasivam; Kari Hemminki; Asta Försti; Obul Reddy Bandapalli; Matthias Schlesner; Tianhui Chen; Rolf Sijmons; Dagmara Dymerska; Katarzyna Golebiewska; Magdalena Kuswik; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2021-01-19       Impact factor: 2.857

5.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.